The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 2SEVENTY BIO INC | COMMON STOCK | 901384107 | 34,066 | 2,341,313 | SH | SOLE | 2,341,313 | 0 | 0 | ||
| 5 01 ACQUISITION CORP | COM CL A | 33836P105 | 2,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | 98,021 | 5,991,479 | SH | SOLE | 5,991,479 | 0 | 0 | ||
| AKOUOS INC | COM | 00973J101 | 13,358 | 1,975,984 | SH | SOLE | 1,975,984 | 0 | 0 | ||
| ALECTOR INC | COM | 014442107 | 38,375 | 4,056,548 | SH | SOLE | 4,056,548 | 0 | 0 | ||
| ALIGOS THERAPEUTICS INC | COM | 01626L105 | 4,343 | 3,948,360 | SH | SOLE | 3,948,360 | 0 | 0 | ||
| ALLOGENE THERAPEUTICS INC | COM | 019770106 | 48,473 | 4,488,200 | SH | SOLE | 4,488,200 | 0 | 0 | ||
| ANAPTYSBIO INC | COM | 032724106 | 191,861 | 7,521,024 | SH | SOLE | 7,521,024 | 0 | 0 | ||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 354,028 | 5,183,431 | SH | SOLE | 5,183,431 | 0 | 0 | ||
| ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 7,937 | 415,322 | SH | SOLE | 415,322 | 0 | 0 | ||
| ARGENX SE | SPONSORED ADR | 04016X101 | 6,188 | 17,527 | SH | SOLE | 17,527 | 0 | 0 | ||
| ARVINAS INC | COM | 04335A105 | 138,956 | 3,123,300 | SH | SOLE | 3,123,300 | 0 | 0 | ||
| ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 1,487 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 2,809 | 27,208 | SH | SOLE | 27,208 | 0 | 0 | ||
| ATEA PHARMACEUTICALS INC | COM | 04683R106 | 35,192 | 6,184,861 | SH | SOLE | 6,184,861 | 0 | 0 | ||
| AVEO PHARMACEUTICALS INC | COM NEW | 053588307 | 5,354 | 650,489 | SH | SOLE | 650,489 | 0 | 0 | ||
| AVIDITY BIOSCIENCES INC | COM | 05370A108 | 47,345 | 2,899,285 | SH | SOLE | 2,899,285 | 0 | 0 | ||
| BCLS ACQUISITION CORP | COM CL A | G0904B105 | 2,004 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| CAREMAX INC | *W EXP 06/08/202 | 14171W111 | 709 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 13,010 | 3,236,352 | SH | SOLE | 3,236,352 | 0 | 0 | ||
| CHINOOK THERAPEUTICS INC | COM | 16961L106 | 13,565 | 690,000 | SH | SOLE | 690,000 | 0 | 0 | ||
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 26,126 | 1,330,263 | SH | SOLE | 1,330,263 | 0 | 0 | ||
| CULLINAN ONCOLOGY INC | COM | 230031106 | 14,656 | 1,143,218 | SH | SOLE | 1,143,218 | 0 | 0 | ||
| DESIGN THERAPEUTICS INC | COM | 25056L103 | 42,122 | 2,519,268 | SH | SOLE | 2,519,268 | 0 | 0 | ||
| DESIGN THERAPEUTICS INC | COM | 25056L103 | 1,060 | 63,400 | SH | Call | SOLE | 63,400 | 0 | 0 | |
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 34,373 | 3,493,194 | SH | SOLE | 3,493,194 | 0 | 0 | ||
| ERASCA INC | COM | 29479A108 | 5,292 | 678,441 | SH | SOLE | 678,441 | 0 | 0 | ||
| EUCRATES BIOMEDICAL ACQU COR | SHS | G3141W106 | 2,004 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| EUCRATES BIOMEDICAL ACQU COR | *W EXP 10/23/202 | G3141W122 | 668 | 66,666 | SH | SOLE | 66,666 | 0 | 0 | ||
| FRAZIER LIFESCIENCES ACQU CO | *W EXP 11/30/202 | G3710A113 | 665 | 66,665 | SH | SOLE | 66,665 | 0 | 0 | ||
| FRAZIER LIFESCIENCES ACQU CO | CL A SHS | G3710A105 | 4,862 | 487,615 | SH | SOLE | 487,615 | 0 | 0 | ||
| GALAPAGOS NV | SPON ADR | 36315X101 | 136,341 | 3,197,500 | SH | SOLE | 3,197,500 | 0 | 0 | ||
| GERON CORP | COM | 374163103 | 5,387 | 2,301,980 | SH | SOLE | 2,301,980 | 0 | 0 | ||
| GOSSAMER BIO INC | COM | 38341P102 | 49,847 | 4,160,887 | SH | SOLE | 4,160,887 | 0 | 0 | ||
| GRACELL BIOTECHNOLOGIES INC | SPONSORED ADS | 38406L103 | 6,187 | 1,921,310 | SH | SOLE | 1,921,310 | 0 | 0 | ||
| GRAPHITE BIO INC | COM | 38870X104 | 5,015 | 1,582,135 | SH | SOLE | 1,582,135 | 0 | 0 | ||
| HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 3,960 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| HOOKIPA PHARMA INC | COM | 43906K100 | 6,700 | 5,000,000 | SH | SOLE | 5,000,000 | 0 | 0 | ||
| ITEOS THERAPEUTICS INC | COM | 46565G104 | 771 | 40,480 | SH | SOLE | 40,480 | 0 | 0 | ||
| JANUX THERAPEUTICS INC | COM | 47103J105 | 19,245 | 1,421,319 | SH | SOLE | 1,421,319 | 0 | 0 | ||
| JIYA ACQUISITION CORP | COM CL A | 47760M102 | 4,985 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| KINNATE BIOPHARMA INC | COM | 49705R105 | 2,091 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
| KRONOS BIO INC | COM | 50107A104 | 1,095 | 326,780 | SH | SOLE | 326,780 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 90,680 | 6,638,371 | SH | SOLE | 6,638,371 | 0 | 0 | ||
| KYMERA THERAPEUTICS INC | COM | 501575104 | 17,331 | 796,093 | SH | SOLE | 796,093 | 0 | 0 | ||
| MACROGENICS INC | COM | 556099109 | 3,221 | 930,955 | SH | SOLE | 930,955 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 70,928 | 1,015,572 | SH | SOLE | 1,015,572 | 0 | 0 | ||
| MORPHIC HLDG INC | COM | 61775R105 | 111,829 | 3,951,566 | SH | SOLE | 3,951,566 | 0 | 0 | ||
| NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 7,078 | 541,108 | SH | SOLE | 541,108 | 0 | 0 | ||
| NUVALENT INC | COM | 670703107 | 796 | 40,970 | SH | SOLE | 40,970 | 0 | 0 | ||
| NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 2,158 | 963,333 | SH | SOLE | 963,333 | 0 | 0 | ||
| NUVATION BIO INC | COM CL A | 67080N101 | 31,128 | 13,896,543 | SH | SOLE | 13,896,543 | 0 | 0 | ||
| OMEGA ALPHA SPAC | CL A | G6749V107 | 497 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| ORIC PHARMACEUTICALS INC | COM | 68622P109 | 10,938 | 3,418,068 | SH | SOLE | 3,418,068 | 0 | 0 | ||
| OVID THERAPEUTICS INC | COM | 690469101 | 11,256 | 6,117,400 | SH | SOLE | 6,117,400 | 0 | 0 | ||
| POSEIDA THERAPEUTICS INC | COM | 73730P108 | 9,355 | 2,650,000 | SH | SOLE | 2,650,000 | 0 | 0 | ||
| PRAXIS PRECISION MEDICINES I | COM | 74006W108 | 3,397 | 1,496,324 | SH | SOLE | 1,496,324 | 0 | 0 | ||
| PRECISION BIOSCIENCES INC | COM | 74019P108 | 6,547 | 5,035,971 | SH | SOLE | 5,035,971 | 0 | 0 | ||
| PROTHENA CORP PLC | SHS | G72800108 | 702,355 | 11,584,280 | SH | SOLE | 11,584,280 | 0 | 0 | ||
| REATA PHARMACEUTICALS INC | CL A | 75615P103 | 967 | 38,467 | SH | SOLE | 38,467 | 0 | 0 | ||
| RELAY THERAPEUTICS INC | COM | 75943R102 | 93,145 | 4,163,824 | SH | SOLE | 4,163,824 | 0 | 0 | ||
| REVOLUTION MEDICINES INC | COM | 76155X100 | 35,532 | 1,801,847 | SH | SOLE | 1,801,847 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 331,560 | 2,999,453 | SH | SOLE | 2,999,453 | 0 | 0 | ||
| SEAGEN INC | COM | 81181C104 | 39,105 | 285,793 | SH | SOLE | 285,793 | 0 | 0 | ||
| SELECTA BIOSCIENCES INC | COM | 816212104 | 5,740 | 3,500,000 | SH | SOLE | 3,500,000 | 0 | 0 | ||
| SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 98,720 | 3,460,208 | SH | SOLE | 3,460,208 | 0 | 0 | ||
| SURFACE ONCOLOGY INC | COM | 86877M209 | 4,082 | 3,924,713 | SH | SOLE | 3,924,713 | 0 | 0 | ||
| SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 135 | 66,665 | SH | SOLE | 66,665 | 0 | 0 | ||
| TANGO THERAPEUTICS INC | COM | 87583X109 | 15,209 | 4,201,414 | SH | SOLE | 4,201,414 | 0 | 0 | ||
| TEMPEST THERAPEUTICS INC | COM | 87978U108 | 1,794 | 1,031,268 | SH | SOLE | 1,031,268 | 0 | 0 | ||
| TURMERIC ACQUISITION CORP | CL A | G9127T108 | 1,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| TURMERIC ACQUISITION CORP | *W EXP 10/08/202 | G9127T124 | 333 | 33,333 | SH | SOLE | 33,333 | 0 | 0 | ||
| VENTYX BIOSCIENCES INC | COM | 92332V107 | 13,964 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| VOYAGER THERAPEUTICS INC | COM | 92915B106 | 28,143 | 4,753,907 | SH | SOLE | 4,753,907 | 0 | 0 | ||
| XENCOR INC | COM | 98401F105 | 137,240 | 5,282,516 | SH | SOLE | 5,282,516 | 0 | 0 | ||
| ZAI LAB LTD | ADR | 98887Q104 | 69,435 | 2,030,252 | SH | SOLE | 2,030,252 | 0 | 0 | ||